DK1699474T3 - Probiotic tablet formulations - Google Patents

Probiotic tablet formulations

Info

Publication number
DK1699474T3
DK1699474T3 DK04804142.0T DK04804142T DK1699474T3 DK 1699474 T3 DK1699474 T3 DK 1699474T3 DK 04804142 T DK04804142 T DK 04804142T DK 1699474 T3 DK1699474 T3 DK 1699474T3
Authority
DK
Denmark
Prior art keywords
zone
organism
probiotic
micro
probiotic micro
Prior art date
Application number
DK04804142.0T
Other languages
Danish (da)
Other versions
DK1699474T4 (en
Inventor
Helene Mathilda Mortensen
Kristian Lund Henriksen
Marianne Winning
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30776514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1699474(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrosan As filed Critical Ferrosan As
Application granted granted Critical
Publication of DK1699474T3 publication Critical patent/DK1699474T3/en
Publication of DK1699474T4 publication Critical patent/DK1699474T4/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

A probiotic tablet comprising a probiotic micro-organism and other nutritionally active ingredients in two zones, a first zone comprising said probiotic micro-organism and precisely selenium, and a second zone comprising at least one said other active ingredient such as iron, other minerals and vitamin B6 kept separated from the probiotic micro-organism of said first zone, the water activity in said probiotic micro-organism containing first zone being no greater than 0.2 and the water content of said tablet being as much as 3% by weight. Good viability of the micro-organisms is obtained despite the relatively high overall moisture content.
DK04804142.0T 2003-12-24 2004-12-21 Probiotic tablet formulations DK1699474T4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0330009.2A GB0330009D0 (en) 2003-12-24 2003-12-24 Probiotic tablet formulations
PCT/EP2004/014545 WO2005063200A2 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations

Publications (2)

Publication Number Publication Date
DK1699474T3 true DK1699474T3 (en) 2010-04-12
DK1699474T4 DK1699474T4 (en) 2013-12-02

Family

ID=30776514

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04804142.0T DK1699474T4 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations

Country Status (15)

Country Link
US (2) US10172793B2 (en)
EP (1) EP1699474B2 (en)
CN (1) CN1913905B (en)
AT (1) ATE453397T1 (en)
AU (1) AU2004308632B2 (en)
CA (1) CA2551581A1 (en)
DE (1) DE602004024924D1 (en)
DK (1) DK1699474T4 (en)
EA (1) EA011321B1 (en)
ES (1) ES2336680T5 (en)
GB (1) GB0330009D0 (en)
NO (1) NO340908B1 (en)
PL (1) PL1699474T5 (en)
UA (1) UA87296C2 (en)
WO (1) WO2005063200A2 (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
AR052472A1 (en) 2005-05-31 2007-03-21 Iams Company PROBIOTIC LACTOBACILOS FOR FELINOS
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
DK1928426T3 (en) * 2005-09-29 2014-12-01 Merck Patent Gmbh Process for the stabilization of pharmaceutical administration forms that contain micro
AU2012244263B2 (en) * 2005-10-12 2015-09-17 Genencor International, Inc. Stable, durable granules with active agents
US8524304B2 (en) 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20080241805A1 (en) 2006-08-31 2008-10-02 Q-Track Corporation System and method for simulated dosimetry using a real time locating system
US9084434B2 (en) 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
CN101711158A (en) 2007-02-01 2010-05-19 爱默思公司 Method for decreasing inflammation and stress in a mammal using glucose antimetaboltes, avocado or avocado extracts
CN101273737B (en) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 Method for preparing fermented milk drinks having higher viable counts at normal temperature
US9078824B2 (en) * 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN101259278B (en) * 2008-04-21 2010-06-02 黄芝芳 Optimum matching multiple water-soluble vitamin medicinal composition containing high-efficiency bacteriostat and preparation thereof
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2210593A3 (en) * 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR101102364B1 (en) * 2009-09-18 2012-01-03 한림제약(주) Pharmaceutical composition comprising bisphosphonate derivative and high amount of cholecalciferol
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
IT1403661B1 (en) * 2011-01-28 2013-10-31 Probiotical Spa EFFERVESCENT COMPOSITION IN THE SOLID FORM FOR USE IN VAGINAL APPLICATIONS FOR THE TREATMENT OF VAGINAL INFECTIONS.
ITMI20110792A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF BACTERIA BELONGING TO THE BIFIDOBACTERIUM TYPE FOR USE IN THE TREATMENT OF HYPERCOLESTEROLEMIA.
ITMI20110793A1 (en) 2011-05-09 2012-11-10 Probiotical Spa STRAINS OF PROBIOTIC BACTERIA AND SYNBIOTIC COMPOSITION CONTAINING THEMSELVES INTENDED FOR THE BABY FOOD.
ITMI20110791A1 (en) 2011-05-09 2012-11-10 Probiotical Spa BACTERIA OF BACTERIA ABLE TO METABOLIZE THE OXALATES.
ITRM20110477A1 (en) 2011-09-09 2013-03-10 Giovanni Mogna COMPOSITION INCLUDING N-ACETYLCISTEIN AND / OR LYSOZYME MICROINCAPSULATE GASTROPROTECT IN ASSOCIATION WITH PROBIOTIC BACTERES ABLE TO RESTORE THE BARRIER EFFECT OF THE STOMACH THAT IS LOST DURING THE PHARMACOLOGICAL TREATMENT OF
ITMI20111718A1 (en) 2011-09-23 2013-03-24 Probiotical Spa A WATERPROOF MOISTURE AND OXYGEN MATERIAL FOR PACKAGING DIETARY, COSMETIC AND MEDICINAL PRODUCTS.
DE202011109556U1 (en) * 2011-10-24 2012-10-29 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Ferrous vitamin composition
ITMI20130793A1 (en) 2013-05-14 2014-11-15 Probiotical Spa COMPOSITION INCLUDING LACTIC BACTERIA FOR USE IN THE PREVENTIVE AND / OR CURATIVE TREATMENT OF THE RECURRENT CYCLES.
CN110179835A (en) 2014-05-12 2019-08-30 美国宝微技术股份有限公司 Improve the composition of human skin health and its prepares the purposes in product
WO2016003870A1 (en) * 2014-07-01 2016-01-07 Tntgamble, Inc. Bi-layer dual release probiotic tablets
CN104489646B (en) * 2014-11-19 2016-08-31 李雅君 A kind of fruit and vegerable probiotic tablet and preparation method thereof
BR112017024265B1 (en) 2015-05-11 2022-08-09 Mybiotics Pharma Ltd METHODS FOR GROWING A BIOFILM OF PROBIOTIC BACTERIA IN SOLID PARTICLES
JP7017849B2 (en) * 2015-09-11 2022-02-09 シムライズ アーゲー Oral dosage form
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
WO2017060477A1 (en) * 2015-10-07 2017-04-13 Bifodan A/S Probiotic formulation
WO2017065623A1 (en) * 2015-10-16 2017-04-20 Mendoza Wendell Stable composition of vitamin c and zinc tablet
CN105962376A (en) * 2016-04-28 2016-09-28 内蒙古乌审召生态产业发展有限公司 Spirulina tablets with layer structures and preparation method thereof
IL294171A (en) 2016-05-25 2022-08-01 Mybiotics Pharma Ltd Composition and methods for microbiota therapy
WO2018087208A1 (en) * 2016-11-10 2018-05-17 Nestec Sa Composition in powder form comprising iron and probiotic bacteria
IT201700011337A1 (en) * 2017-02-02 2018-08-02 S I I T S R L Servizio Int Imballaggi Termosaldanti MULTI-LAYER COMPRESS FOR THE ADMINISTRATION OF MAGNESIUM
CN107821753A (en) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 A kind of pet probiotic granulate preparation and preparation method thereof
WO2019101832A1 (en) * 2017-11-27 2019-05-31 Dsm Ip Assets B.V. Freeze-dried multiparticulate solid dosage form
CN112512309A (en) 2018-05-29 2021-03-16 美国宝微技术股份有限公司 Compositions and methods for increasing survival of aquatic animals
US11254619B2 (en) 2019-04-12 2022-02-22 Jeffrey Hanson Robbins Dry composition including effervescent agents, biostimulant, and plant nutrient
US11247944B2 (en) 2019-04-12 2022-02-15 Jeffrey Hanson Robbins Potassium citrate mixture formed from a dry fertilizer and methods thereof
CN113710237A (en) * 2019-04-15 2021-11-26 奥古斯特·皮·松耶尔生物医学研究所(Idibaps) Long-term stable live fecal microbiota composition
CN110934751B (en) * 2019-12-31 2022-09-02 成都三勒浆药业集团四川华美制药有限公司 Double-layer buccal tablet for oral health and preparation method thereof
FR3125945A1 (en) * 2021-08-03 2023-02-10 Setalg Composition for protecting a microorganism in an acidic environment.

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
EP0116736B1 (en) † 1983-02-18 1987-02-25 NABISCO BRANDS, Inc. Canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4956295A (en) † 1984-05-21 1990-09-11 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
JPH0780754B2 (en) * 1986-08-06 1995-08-30 エーザイ株式会社 Multi-granular sustained-release tablet
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Colonic drug delivery system
US5310555A (en) † 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5885481A (en) 1993-07-16 1999-03-23 Amoco Corporation Efficiency oxygen-scavenging compositions and articles
FR2716341B1 (en) † 1994-02-23 1996-05-10 Gervais Danone Sa Food composition comprising a cookie or a chocolate shell and a filling based on dairy product, fermented or not.
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
SE513815C2 (en) 1995-08-25 2000-11-06 Wasa Medicals Ab Process for the preparation of tablets containing live microorganisms and with oligosaccharides in the tablet material
US5774056A (en) 1996-05-30 1998-06-30 Engineered Products Co. Gauge for monitoring air filters
US6083585A (en) 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
GB2323532B (en) * 1997-03-27 2001-08-22 Bakulesh Mafatlal Khamar Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
NZ503086A (en) 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
SI0931543T1 (en) * 1997-12-19 2002-10-31 Merck Patent Gmbh Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria
US6169387B1 (en) 1997-12-22 2001-01-02 Lifecor, Inc. Battery management apparatus for portable electronic devices
PT956858E (en) * 1998-04-30 2002-04-29 Renata Maria Anna Caval Vesely PHARMACEUTICAL COMPOSITIONS CONTAINING LACTOBACILS FOR THE TREATMENT OF VAGINAL INFECTIONS
DE19819475A1 (en) † 1998-04-30 1999-11-04 Basf Ag Dry microorganism cultures and methods for their production
EP1102595A2 (en) 1998-08-07 2001-05-30 Ganeden Biotech, Inc. Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
EP1042956B1 (en) † 1999-04-09 2006-06-21 Societe Des Produits Nestle S.A. Raw topped pizza dough
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
SE515310C2 (en) 1999-11-25 2001-07-09 Wasa Medicals Ab Tablets containing microorganisms and process for their preparation
US6399114B2 (en) 2000-05-26 2002-06-04 C & D Foreman, Inc. Nutritional system for nervous system disorders
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
PT1429802E (en) 2001-09-28 2013-01-24 Tntgamble Inc Delivery system for biological component
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE10206995B4 (en) † 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Micronutrient combination product with pro- and prebiotics
DE20202562U1 (en) 2002-02-19 2002-05-23 Orthomol Pharmazeutische Vertr Micronutrient combination product with probiotics and prebiotics
EP1344458A1 (en) † 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
US8460917B2 (en) 2002-03-21 2013-06-11 Bifodan A/S Lactobacillus strains
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US9210945B2 (en) † 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
ES2708659T3 (en) † 2009-08-13 2019-04-10 Kellog Co Food binder with low water activity and procedures related to it

Also Published As

Publication number Publication date
EP1699474A2 (en) 2006-09-13
EA200601214A1 (en) 2006-12-29
ES2336680T3 (en) 2010-04-15
DK1699474T4 (en) 2013-12-02
AU2004308632A1 (en) 2005-07-14
US20190091145A1 (en) 2019-03-28
DE602004024924D1 (en) 2010-02-11
CN1913905B (en) 2010-09-08
ES2336680T5 (en) 2014-01-20
WO2005063200A2 (en) 2005-07-14
UA87296C2 (en) 2009-07-10
US10172793B2 (en) 2019-01-08
ATE453397T1 (en) 2010-01-15
EA011321B1 (en) 2009-02-27
US20070269515A1 (en) 2007-11-22
PL1699474T5 (en) 2014-02-28
AU2004308632B2 (en) 2010-07-01
PL1699474T3 (en) 2010-06-30
EP1699474B1 (en) 2009-12-30
WO2005063200A3 (en) 2005-11-24
CN1913905A (en) 2007-02-14
EP1699474B2 (en) 2013-10-23
NO340908B1 (en) 2017-07-10
CA2551581A1 (en) 2005-07-14
NO20063410L (en) 2006-09-22
GB0330009D0 (en) 2004-01-28

Similar Documents

Publication Publication Date Title
NO20063410L (en) Probiotic tablet formulations
Wu et al. Effect of probiotic Bacillus subtilis Ch9 for grass carp, Ctenopharyngodon idella (Valenciennes, 1844), on growth performance, digestive enzyme activities and intestinal microflora
DK0973413T3 (en) Food formulations containing lacto-N-neotetraose
ATE419829T1 (en) EXTRACTS FROM PUERARIA MIRIFICA AND THEIR EXTRACTION
HUP0301939A2 (en) Novel probiotics for pet food applications
UA95967C2 (en) Local topical administration formulations containing indoxacarb
DE69924141D1 (en) ORAL ADMINISTRATION OF LACTOBACILLUS FOR THE TREATMENT AND PREVENTION OF UROGENITAL INFECTIONS
NZ519980A (en) Pet food composition for treating helicobacter species in pets
DE60133581D1 (en) PROBIOTIC COMPOUNDS DERIVED BY LACTOBACILLUS CASEI KE01 STEM
HUP0104782A2 (en) Method for increasing pet activity
DE502005010277D1 (en) TEINEN
ATE514418T1 (en) RAPIDLY DISRUPTING SOLID DOSAGE FORMS WITH NON-FRUABLE CONSISTENCY AND PULLULAN
DK2288360T3 (en) Isolated Lactobacillus plantarum strain Inducia DSM21379 as a probiotic that enhances natural immunity, as well as food products and medicinal preparations comprising the
TW200700074A (en) Inducer of t cell apoptosis
UA88165C2 (en) Use of trisubstituted benzopyranones
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
ATE451110T1 (en) COMPOSITION WITH IMMUNE-REGULATORY EFFECTS FROM LACTOBACILLUS PENTOSUS
WO2004089290A3 (en) Novel probiotic compositions and methods of using the same
FR2827774B1 (en) PHARMACEUTICAL AND / OR DIETARY PREPARATIONS CONTAINING ACTIVE PLANT VEGETABLE EXTRACT AND PROBIOTIC MICROORGANISMS
TW200637542A (en) Lipase inhibitor, preventing and treating agent of skin disease
CA2427080A1 (en) Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation
TW200509794A (en) Novel anthelmintic and insecticidal compositions
ATE285757T1 (en) INACTIVATED MICROORGANISMS CONTAINING PHARMACOLOGICALLY ACTIVE SUBSTANCES
DE50210605D1 (en) SPICE HERB PREPARATION
Jinpeng Selenium and Kashin-Beck Disease